期刊文献+

成人先天性心脏病合并Eisenmenger综合征患者的临床特征

Clinical features of adult patients with Eisenmenger syndrome associated with different types ofcongenital heart disease
原文传递
导出
摘要 目的了解成人先天性心脏病(CHD)合并Eisenmenger综合征患者的临床特征。方法自2007年5月至2010年10月,在全国31个临床中心入选经超声心动图和右心导管检查确诊的成人CHD合并Eisenmenger综合征患者,收集所有患者的年龄、性别、体质指数(BMI)等人口学指标,症状、体征、世界卫生组织肺动脉高压功能分级(WHO-FC)、6min步行距离等临床指标和血流动力学指标。分析不同类型CHD合并Eisenmenger综合征患者的临床特征和血流动力学的差异。结果共纳入224例患者,其中房间隔缺损67例(29.9%),室间隔缺损104例(46.4%),动脉导管未闭53例(23.7%);男67例(29.9%),女157例(70.1%);年龄15~63岁,平均(29.6±9.9)岁;平均BMI(19.9±4.0)kg/m。、6min步行距离(371±75)m。WHO-FCⅡ级158例(70.5%),Ⅲ级64例(28.6%);173例(77.2%)患者心电图表现出右室肥厚。患者平均右房压(8.9±5.7)mmHg(1mmHg=0.133kPa)、肺动脉平均压(77.2±19.1)mmHg、心指数(3.03±1.35)L·min·m-2、肺血管阻力为(1621±887)dyn·S·cm-5。结论CHD合并Eisenmenger综合征患者以中青年女性多见,室间隔缺损患者所占比例最高。CHD患者肺动脉压力和肺血管阻力升高程度与心功能减退不呈平行关系。 Objective To explore the clinical features and hemodynamies of adult patients with Eisenmenger syndrome in different types of congenital heart diseases ( CHD ) . Methods Patients with Eisenmenger syndrome with different types of CHD diagnosed by right heart catheterization were enrolled from 31 clinical centers in China during the period from May 2007 to October 2010. Age, gender, body mass index (BMI), symptoms and signs, World Health Organization functional class (WHO-FC) of pulmonary hypertension, six-minute walk distance (6MWD) and hemodynamics were recorded. All the above indices were analyzed and compared. Results A total of 224 patients with Eisenmenger syndrome with 3 kinds of CHD were enrolled, including atrial septal defect (n = 67 ) , ventricular septal defect (n = 104 ) and patent ductus arteriosus (n =53). Among them, there were 67 males (29.9%) and 157 females (70. 1% ) with a mean age of (29. 6 ± 9. 9) years ( range : 15 - 63 ). Mean BMI was ( 19.9± 4.0) kg/m2 and mean 6MWD (371 ±75) m. The majority of patients were in WHO-FC 1/ (n = 158, 70.5%) and m (n =64, 28.6% ). Electrocardiogram of 77.2% of them indicated hypertrophic right ventricle. Mean right atrial pressure was (8. 9 ±5.7) mm Hg ( 1 mm Hg =0. 133 kPa), mean pulmonary arterial pressure (mPAP) (77.2 ±19.1) mm Hg, cardiac index (3.03 ± 1.35) L ·min-1 · m-2 and pulmonary vascular resistance (PVR) (1621± 887) dyn · s · cm-5. Conclusions The majority of patients with Eisenmenger syndrome with different types of CHD are young females and ventricular septal defect is the most frequent underlyingcause. The deterioration of heart function in patients with Eisenmenger syndrome is non-parallel to mPAP and PVR in CHD.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第20期1546-1549,共4页 National Medical Journal of China
基金 国家“十一五”科技支撑计划(2006BAl01A07)
关键词 心脏缺损 先天性 Eisenmenger复合征 高血压 肺性 疾病特征 Heart defects, congenital Eisenmenger complex Hypertension, pulmonary Disease attributes
  • 相关文献

参考文献13

  • 1McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009, 53 : 1573-1619.
  • 2McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004, 126: 14S-34S.
  • 3ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six- minute walk test. Am J Respir Crit Care Med, 2002, 166: 111- 117.
  • 4Berger RM, Beghetti M, Gali N, et al. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo- controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. Int J Cardiol, 2010, 144: 373-375.
  • 5Beghetti M, Tissot C. Pulmonary arterial hypertension in congenital heart diseases. Semin Respir Crit Care Med, 2009, 30 : 421-428.
  • 6马桂琴,吴明昌,何建平,金兰中,李国敏.新生儿先天性心脏病385例彩色多普勒超声诊断及其临床意义[J].中华围产医学杂志,2001,4(2):92-95. 被引量:24
  • 7Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease : an epidemiologic perspective from a Dutch registry. Int J Cardiol, 2007, 120: 198- 204.
  • 8Lindinger A, Sehwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study ( July 2006 to June 2007 ). Klin Padiatr, 2010, 222 : 321-326.
  • 9孙云娟,逢坤静,曾伟杰,王浩,何建国.先天性心脏病相关性肺动脉高压的临床筛查[J].中华医学杂志,2012,92(16):1091-1094. 被引量:12
  • 10Keith JD, Rowe RD, Vlad P. Heart disease in infancy and childhood. New York: MacMillan Publishing Company Inc, 1958.

二级参考文献18

  • 1庞昕焱,李卫华,宋惠民,苏润毅,于建华,李跃华,毕研文,李守先.单向活瓣补片在合并重度肺动脉高压的先天性心脏病患者手术治疗中的应用[J].中华医学杂志,2004,84(11):888-890. 被引量:31
  • 2Berman EB,Barst RJ.Eisenmenger' s Syndrome:current management.Prog Cardiovase Dis,2002,45:129-138.
  • 3McLanghlin VV,Archer SL,Badesch DB,et al.Pulmonary Hypertension Association.ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension:a Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.Circulation,2009,119:2250-2294.
  • 4Beat F,Langford K,William T,et al.Ventricular Septal defect with increased pulmonary vascular resistance.Am J Cardiol,1974,33:403-409.
  • 5Saha A,Balakrishnan KG,Jaiswal PK,et al.Prognosis for patients with Eisenmenger Syndrome fo various aetiology.Int J Cardiol,1994,45:199-207.
  • 6Brook MM,Fineman JR,Bolinger AM,et al.Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects.Circulation,1994,90:1287-1293.
  • 7Kirklin KW,Barrat-Boyes BG.Ventricular septul defects//Kirklin KW,Barrat-Boyes BW,eds.Cardiac Surgery.2nd.Newyork:Chruchile Liveington,1993:749-824.
  • 8Kgnnan BR,Sivasankaran S,Tharakan JA,et al.Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.Indian Heart J,2003,55:161-166.
  • 9Yan C,Zhao S,Jiang S,et al.Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults.Heart,2007,93:514-518.
  • 10Berner M,Beghetti M,Spahr-Schopfer I,et al.Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.Am J Cardiol,1996,77:532-535.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部